Intech Investment Management LLC Purchases 4,138 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Intech Investment Management LLC increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 92.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 8,612 shares of the medical instruments supplier's stock after buying an additional 4,138 shares during the quarter. Intech Investment Management LLC's holdings in ICU Medical were worth $1,336,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Arizona State Retirement System increased its stake in ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after purchasing an additional 65 shares in the last quarter. Equitable Trust Co. boosted its stake in ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock valued at $822,000 after purchasing an additional 84 shares during the last quarter. Gagnon Securities LLC raised its position in ICU Medical by 0.5% in the 4th quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier's stock valued at $4,481,000 after buying an additional 137 shares during the last quarter. Wealthspire Advisors LLC lifted its position in shares of ICU Medical by 6.4% during the fourth quarter. Wealthspire Advisors LLC now owns 2,660 shares of the medical instruments supplier's stock valued at $413,000 after purchasing an additional 160 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D grew its holdings in shares of ICU Medical by 1.6% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 12,370 shares of the medical instruments supplier's stock valued at $1,919,000 after acquiring an additional 191 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

Remove Ads

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company's stock, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 6.70% of the company's stock.

ICU Medical Price Performance

NASDAQ:ICUI traded up $0.06 during trading hours on Tuesday, hitting $149.88. 238,271 shares of the company's stock traded hands, compared to its average volume of 256,802. ICU Medical, Inc. has a 52 week low of $93.36 and a 52 week high of $196.26. The business's fifty day simple moving average is $155.69 and its two-hundred day simple moving average is $164.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm has a market cap of $3.67 billion, a P/E ratio of -32.80 and a beta of 0.73.

Analyst Ratings Changes

Several brokerages have recently issued reports on ICUI. Raymond James set a $97.00 price target on shares of ICU Medical in a research note on Wednesday, March 12th. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. Finally, StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, March 18th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.